2024 Hereditary Cancer Genetics: Incorporation into Clinical Care — On Demand


2024 Hereditary Cancer Genetics: Incorporation into Clinical Care — On Demand Banner



Date & Location
Wednesday, November 13, 2024, 8:00 AM - Saturday, May 31, 2025, 11:00 PM

Specialties
Specialties - Genetics, Oncology and Hematology, Pediatric Oncology, Surgical Oncology

Overview

Originally presented live on September 27—28, 2024, this conference offers professional training in clinical cancer genetics, hosted by one of the world’s largest and most renowned cancer genetics centers. The comprehensive program features presentations and panel discussions led by distinguished experts specializing in disease-specific management. Designed to provide a solid foundation in cancer genetics, the program explores the implications of genetic testing for patient care and showcases the latest advancements in cancer genomics.

Featured topics include:

— Predisposition, Prediction and Prevention: A Window on the Future of Pediatric Cancer
— Current Topics in Hereditary Breast, Gynecologic, Gastrointestinal, and Genitourinary Cancers
— Hereditary Hematologic Malignancies and Rare Cancer Syndromes
— Therapeutic Implications and Utility of Paired Tumor/Normal Sequencing
— Comprehensive High Risk Cancer Surveillance and Management
— Novel Genetics Care Delivery Models in Oncology
— Delivery of Genetics Care to Historically Underrepresented Populations

Additionally, the program includes a keynote presentation and a combined Department of Medicine and Department of Pediatrics Grand Rounds Lecture, featuring the prestigious Niehaus, Southworth, Weissenbach Award and Visiting Professorship. This year’s lecture is delivered by David Malkin, MD, FRCP(C), from the Hospital for Sick Children (SickKids), presenting on Predisposition, Prediction, and Prevention: A Window on the Future of Pediatric Cancer.

For more information about this program, including a detailed list of presentations, please click here to view the brochure from the live conference.

This program is designed for practicing medical oncologists, genetic counselors, advanced practice providers, nurses, and other healthcare professionals interested in integrating genetic testing into patient care. Please note that Category 1 Continuing Education Units for Genetic Counselors are not available for the on-demand version of this conference.

Objectives
At the conclusion of this program, learners will be able to:

  1. Identify clinical features of hereditary cancer predisposition syndromes
  2. Evaluate the recommended surveillance and risk reduction interventions for patients with hereditary cancer predisposition syndromes
  3. Enhance awareness of implications of germline genetic testing on therapeutic management of patients with cancer, including oncological and surgical interventions
  4. Apply the understanding of tumor profiling results to identify patients at risk for hereditary cancer syndromes

Registration

Access to the course content requires registration. Once registered, all materials, including relevant financial disclosures and instructions for claiming credit, are located under the 'Course Content' tab. This on-demand program is available for purchase until May 31, 2025. For those that purchase this on demand, access to the content, as well as the opportunity to claim credit, is available through August 30, 2025. To enroll, please click the 'Register' tab at the top of the page.

Discounted registration is available for specific groups. If eligible, you will receive further instructions and a promotion code to use during registration. View our Policy on Registration Discounts for more information and to submit a request. Please note that after your payment has been processed, no further promotional discounts or adjustments will be made to your registration.

On Demand Access Fees
Physicians (MDs, PhDs, and DOs): $300
Advanced Practice Providers and Genetic Counselors: $200
Nurses, and Other Healthcare Providers: $150
Health Profession Students: $125
MSK Employees: Complimentary

This Memorial Sloan Kettering Continuing Medical Education on demand program is non-refundable.


Accreditation

Memorial Sloan Kettering Cancer Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

AMA Credit Designation Statement

Memorial Sloan Kettering Cancer Center designates this enduring material for a maximum of 10.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

MOC/CC Recognition Statement

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to:

— 10.50 Medical Knowledge MOC Points in the American Board of Internal Medicine's Maintenance (ABIM) of Certification Assessment Recognition program; and
— 10.50 Accredited CME and Self-Assessment MOC points in the American Board of Surgery’s (ABS) Continuous Certification program.

It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM or ABS MOC credit.

Please note that Category 1 Continuing Education Units for Genetic Counselors are not available for the on-demand version of this conference.



Recorded/Review Date: September 27-28, 2024 | Original Release Date: November 13, 2024 | Termination Date: August 30, 2025